Mostrando 10 resultados de: 10
Filtros aplicados
Publisher
American Journal of Therapeutics(4)
Revista Latinoamericana de Hipertension(3)
Acta Bioquimica Clinica Latinoamericana(1)
Anales de Medicina Interna(1)
Medicina Clinica(1)
Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes
ArticleAbstract: Type 2 diabetes mellitus is a metabolic disorder that results from defects in both insulin secretionPalabras claves:Free fatty acids, HOMA, Insulin, Insulin Resistance, Type 2 Diabetes mellitusAutores:Acosta K., Aparicio D., Arráiz N., Bermúdez F.A., Briceño C., Bustamante M., Cabrera M., Cano R.A., Cano-Ponce C., Gómez J., Hernández-Hernandez R., Joselyn Zula, Leal E.M., Manuel V., Mengual-Moreno E., Rodriguez M., Valdelamar L., Valmore BermúdezFuentes:googlescopusIncreased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela
ArticleAbstract: The aims of this study were to determine Lipoprotein (a) [Lp(a)] concentrations in a sample of subjePalabras claves:adolescents, CHILDREN, CVD risk factors, Family history, Lipoprotein (a)Autores:Almarza J., Cano-Peñaloza R., Cano-Ponce C., García-Camacho D., Hernández-Hernandez R., Israili Z.H., Mengual-Moreno E., Sorell L.T., Souki-Rincón A., Torres D., Urdaneta J., Valmore Bermúdez, Velasco M.Fuentes:scopusMalondialdehide and reduced glutathione increase in patients with chronic stable ischaemic cardiopathy
ArticleAbstract: BACKGROUND AND OBJECTIVE: Cardiovascular diseases are associated with the ischemia/reperfusion phenoPalabras claves:Chronic ischemic heart disease, Coronary disease, Oxidation/antioxidationAutores:Bermúdez-Arias F., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Mengual-Moreno E., Valmore BermúdezFuentes:scopusMetformin plus low-dose glimeperide significantly improves homeostasis model assessment for insulin resistance (HOMA<inf>IR</inf>) and β-cell function (HOMA<inf>β-cell</inf>) without hyperinsulinemia in patients with type 2 diabetes mellitus
Conference ObjectAbstract: OBJECTIVE: Type 2 diabetes mellitus is characterized by insulin resistance and defects in insulin sePalabras claves:Glimeperide, HOMA, Homeostasis model assessment, Insulin Resistance, Metformin, Type 2 Diabetes mellitus, β-cell functionAutores:Bermúdez-Arias F., Cano R.A., Cano-Ponce C., Ciscek A., Contreras F., Hernández-Hernandez R., Israili Z.H., Leal E.M., Lemus M.A., Medina M.T., Seyfi H.A., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusPharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopusLipoprotein (a) in an urban population of Venezuela: Evidence that estrogenic deprivation increase in lipoprotein (A) levels is transitory
ArticleAbstract: Background: Lipoprotein (a) [Lp (a)] is an independent risk factor for coronary artery disease and nPalabras claves:Apo (a), Hormonal replacement therapy, Lipoprotein (a), risk factor, Tissue plasminogen activatorAutores:Amell De Díaz A., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Sorell Gómez L., Valmore BermúdezFuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusResistin is associated with C reactive protein and cardiovascular risk markers in obese children
ArticleAbstract: The aim of this study was to evaluate seric levels of resitin and their association with highsensitiPalabras claves:Cardiovascular disease risk, Highsensitivity C reactive protein, Nitric oxide, obesity, Plasmatic lipids., ResistinAutores:Arráiz N., Cano-Ponce C., Carem Prieto, Garcia D., Linares S., Pérez-Jiménez F., Souki-Rincón A., Valero P.Fuentes:scopusPrevalence of different lipid profile abnormalities in the consultation of cardiovascular risk factors from the "Dr. Félix Gómez" Endocrine and Metabolic Diseases Research Center in the period from January 2006 to January 2007
ArticleAbstract: Objective: Isolated (or mixed with other dyslipidemias) low HDLc levels are risk factors for coronarPalabras claves:Cardiovascular disease, dyslipidemia, Low isolated HDLc, PREVALENCEAutores:Cano-Ponce C., Luti Y., Mengual-Moreno E., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopus